Costilla Vanessa C, Foxx-Orenstein Amy E, Mayer Anita P, Crowell Michael D
The authors are affiliated with the Mayo Clinic in Scottsdale, Arizona. Dr. Costilla is a Resident in the Department of Internal Medicine. Dr. Mayer is an Assistant Professor in the Division of Women's Health Internal Medicine. Dr. Crowell is a Professor and Dr. Foxx-Orenstein is an Associate Professor in the Division of Gastroenterology.
Gastroenterol Hepatol (N Y). 2013 Jul;9(7):423-33.
Fecal incontinence (FI) is a devastating disorder that is more prevalent than previously realized. FI is the involuntary loss of stool. Many factors contribute to the pathophysiology of FI, including advanced age, bowel irregularity, parity, and obesity. A detailed history and focused rectal examination are important to making the diagnosis and determining contributing causes. Although multiple diagnostic studies are available to assess the cause of FI, specific guidelines that delineate when testing should be done do not exist. Clinicians must weigh the risk, benefit, and burden of testing against the need for empiric treatment. All types of FI are initially managed in the same way, which includes lifestyle modification to reduce bowel derangements, improved access to toileting, and initiation of a bulking regimen to improve stool consistency. If initial conservative management fails, pharmaco-logic agents, biofeedback, or surgery may be indicated.
大便失禁(FI)是一种严重的疾病,其患病率比之前认为的更高。大便失禁是指粪便不自主排出。许多因素导致大便失禁的病理生理过程,包括高龄、肠道功能紊乱、经产史和肥胖。详细的病史和针对性的直肠检查对于做出诊断和确定病因很重要。虽然有多种诊断性检查可用于评估大便失禁的病因,但尚无明确何时应进行检查的具体指南。临床医生必须权衡检查的风险、益处和负担与经验性治疗的必要性。所有类型的大便失禁最初的处理方式相同,包括改变生活方式以减少肠道紊乱、增加如厕便利性,以及开始采用增加粪便体积的方案以改善粪便稠度。如果初始保守治疗失败,可能需要使用药物、生物反馈或手术治疗。